SCHEMBL16670211

SCHEMBL16670211

Cc1ncc[n+]([O-])c1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1712880 0.78
SCHEMBL16677169 0.76
SCHEMBL16670028 0.70 HCAR2 (0.31)
SCHEMBL11395524 0.70 ALDH1A1 (0.41)
SCHEMBL15900252 0.69 NPSR1 (0.38)
SCHEMBL16669824 0.64 HCAR2 (0.37)
SCHEMBL9617684 0.62
SCHEMBL2629384 0.62
SCHEMBL3932688 0.61 HTT (0.31)
SCHEMBL7850001 0.61 HDAC8 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9439910-B2 Fe(III)-pyrazine complex compounds for treatment and prophylaxis of iron-deficiency phenomena and iron-deficiency anaemia VIFOR (INTERNATIONAL) AG (CH) 2016-09-13 US disclosed
US-9439910-B2 Fe(III)-pyrazine complex compounds for treatment and prophylaxis of iron-deficiency phenomena and iron-deficiency anaemia VIFOR (INTERNATIONAL) AG (CH) 2016-09-13 US disclosed
US-20150119374-A1 FE(III)-PYRAZINE COMPLEX COMPOUNDS FOR TREATMENT AND PROPHYLAXIS OF IRON-DEFICIENCY PHENOMENA AND IRON-DEFICIENCY ANAEMIA VIFOR INT AG (CH) 2015-04-30 US disclosed
US-20150119374-A1 FE(III)-PYRAZINE COMPLEX COMPOUNDS FOR TREATMENT AND PROPHYLAXIS OF IRON-DEFICIENCY PHENOMENA AND IRON-DEFICIENCY ANAEMIA VIFOR INT AG (CH) 2015-04-30 US disclosed